Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-24 Purchase | 2024-05-29 4:16 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 2,500 | $6.4 | $16,000 | 65,839 (Indirect Direct) | View |
| 2022-11-29 Purchase | 2022-12-01 4:01 pm | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 409,836 | $1.22 | $500,000 | 483,741 (Direct) | View |
| 2022-05-11 Sale | 2022-05-12 8:35 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 2,575 | $21.92 | $56,457 | 146,919 (Direct) | View |
| 2021-12-09 Purchase | 2021-12-13 4:02 pm | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 10,000 | $2.0622 | $20,622 | 73,905 (Direct) | View |
| 2021-11-16 Sale | 2021-11-18 4:08 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 31,800 | $29.39 | $934,602 | 149,494 (Direct) | View |
| 2021-11-05 Sale | 2021-11-09 4:05 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $26.23 | $262,300 | 251,294 (Indirect Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:05 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 8,500 | $29.69 | $252,400 | 181,294 (Indirect Direct) | View |
| 2021-10-07 Sale | 2021-10-08 4:18 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 60,000 | $26.25 | $1,574,760 | 269,794 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 4:05 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 2,146 | $19.58 | $42,023 | 186,794 (Direct) | View |
| 2021-04-16 Sale | 2021-04-20 4:05 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $26.23 | $262,300 | 328,940 (Direct) | View |
| 2021-03-17 Sale | 2021-03-19 4:05 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 17,727 | $27.44 | $486,456 | 338,940 (Direct) | View |
| 2021-02-02 Sale | 2021-02-02 9:18 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 25,000 | $30.75 | $768,750 | 471,667 (Direct) | View |
| 2020-12-15 Sale | 2020-12-16 8:55 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 5,549 | $26.02 | $144,385 | 196,667 (Direct) | View |
| 2020-12-02 Sale | 2020-12-04 7:00 pm | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 7,891 | $23.43 | $184,849 | 202,216 (Direct) | View |
| 2020-11-05 Sale | 2020-11-06 8:56 pm | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 23,125 | $22.81 | $527,525 | 213,107 (Direct) | View |
| 2020-08-05 Sale | 2020-08-06 4:07 pm | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 2,500 | $19.68 | $49,200 | 236,232 (Direct) | View |
| 2020-07-24 Purchase | 2020-07-28 09:02 am | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 45,000 | $3.5 | $157,500 | 63,905 (Direct) | View |
| 2020-06-25 Sale | 2020-06-29 9:02 pm | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 10,000 | $20 | $200,000 | 238,732 (Direct) | View |
| 2020-05-12 Sale | 2020-05-14 8:59 pm | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 8,125 | $16 | $130,039 | 245,732 (Direct) | View |
| 2020-05-05 Sale | 2020-05-06 4:09 pm | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 2,500 | $15.88 | $39,700 | 253,857 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-12 Option Award | 2024-06-14 4:20 pm | 2025-06-12 2034-06-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 56,753 | $0 | 122,592 (Direct) | View |
| 2023-11-17 Disposition | 2023-11-20 5:09 pm | N/A N/A | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 483,741 | $0 | 0 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:39 pm | 2024-06-13 2033-06-13 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 55,817 | $0 | 102,411 (Direct) | View |
| 2023-03-14 Option Award | 2023-03-16 4:30 pm | N/A 2033-03-14 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 4:36 pm | 2023-06-07 2032-06-07 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 42,888 | $0 | 76,616 (Direct) | View |
| 2022-05-31 Option Award | 2022-06-02 4:43 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 569 | $9.31 | 33,728 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 4:34 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 301 | $16.61 | 33,159 (Direct) | View |
| 2022-01-14 Option Award | 2022-01-19 4:15 pm | N/A 2032-01-14 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-02 4:15 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 414 | $12.06 | 32,858 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 4:05 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $0 | 251,294 (Direct) | View |
| 2021-11-05 Exercise | 2021-11-09 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $16.23 | 251,294 (Direct) | View |
| 2021-02-04 Gift | 2021-11-03 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 28,000 | $0 | 181,294 (Direct) | View |
| 2021-10-07 Exercise | 2021-10-08 4:18 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 60,000 | $0 | 269,794 (Direct) | View |
| 2021-10-07 Exercise | 2021-10-08 4:18 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 60,000 | $16.23 | 269,794 (Direct) | View |
| 2021-08-31 Option Award | 2021-09-02 4:28 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 314 | $15.92 | 32,444 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-01 4:16 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 634 | $15.77 | 32,130 (Direct) | View |
| 2021-05-25 Option Award | 2021-05-27 4:16 pm | 2022-05-25 2031-05-25 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-05-14 Option Award | 2021-05-18 9:21 pm | 2022-05-14 2031-05-13 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 12,000 | $0 | 198,794 (Direct) | View |
| 2021-04-16 Exercise | 2021-04-20 4:05 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $0 | 328,940 (Direct) | View |
| 2021-04-16 Exercise | 2021-04-20 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $16.23 | 328,940 (Direct) | View |
| 2021-03-17 Exercise | 2021-03-19 4:05 pm | N/A 2026-05-18 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $0 | 338,940 (Direct) | View |
| 2021-03-17 Exercise | 2021-03-19 4:05 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 10,000 | $16.23 | 338,940 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 4:47 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 927 | $10.78 | 31,496 (Direct) | View |
| 2021-02-02 Exercise | 2021-02-02 9:18 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 25,000 | $10.09 | 471,667 (Direct) | View |
| 2021-02-21 Exercise | 2021-02-02 9:18 pm | N/A 2024-11-05 | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 25,000 | $0 | 471,667 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 4:10 pm | N/A 2031-01-15 | Acer Therapeutics Inc. | ACER | ASELAGE STEVE Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-11-19 Gift | 2020-12-04 7:00 pm | N/A N/A | Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director | 3,000 | $0 | 202,216 (Direct) | View |
| 2020-11-30 Option Award | 2020-12-02 4:19 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 1,956 | $5.11 | 30,569 (Direct) | View |
| 2020-08-31 Option Award | 2020-09-02 4:36 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 2,409 | $4.15 | 28,613 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-03 4:24 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 1,112 | $4.495 | 26,204 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 8:00 pm | 2021-05-15 2030-05-14 | Retrophin Inc. | RTRX | ASELAGE STEVE Director | 12,000 | $0 | 257,732 (Direct) | View |
| 2020-05-12 Option Award | 2020-05-14 4:18 pm | 2021-05-12 2030-05-12 | BIOCRYST PHARMACEUTICALS INC | BCRX | ASELAGE STEVE Director | 40,000 | $0 | 40,000 (Direct) | View |